Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Tedizolid
Drug ID BADD_D02135
Description Drug-resistant bacteria, such as methicillin-resistant _Staphylococcus aureus_, vancomycin-resistant _Enterococcus faecium_, and penicillin-resistant _Streptococcus penumoniae_, represent a massive public health threat.[A199086, A199131] Tedizolid is a member of the oxazolidinone class of antibiotics, which includes the previously approved [linezolid] and is generally effective against multidrug-resistant Gram-positive bacteria. Tedizolid is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and is generally more effective and more tolerable than [linezolid].[L11232, A199086, A199050] Tedizolid was approved by the FDA on June 20, 2014, for sale by Cubist Pharmaceuticals as tedizolid phosphate (SIVEXTRO®). This product is currently available as both an oral tablet and as a powder for intravenous injection.[L11232]
Indications and Usage Tedizolid is indicated for the treatment of acute bacterial infections of the skin and skin structure (ABSSSI). To prevent drug resistance, tedizolid should only be used for infections that are caused by susceptible bacteria.[L11232]
Marketing Status approved; investigational
ATC Code J01XX11
DrugBank ID DB14569
KEGG ID D09685
MeSH ID C546016
PubChem ID 11234049
TTD Drug ID D08KBK
NDC Product Code Not Available
UNII 97HLQ82NGL
Synonyms tedizolid | 3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one | torezolid | 3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-hydroxymethyloxazolidin-2-one | TR 700 | TR-700
Chemical Information
Molecular Formula C17H15FN6O3
CAS Registry Number 856866-72-3
SMILES CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Vitreous floaters06.09.01.005--
Vomiting07.01.07.003--
White blood cell count decreased13.01.06.012--
Lymphatic disorder01.09.01.003--Not Available
Transaminases increased13.03.04.036--Not Available
Angiopathy24.03.02.007--Not Available
Infestation23.11.01.002; 11.09.01.001--Not Available
Mental disorder19.07.01.002--Not Available
Optic nerve disorder17.04.05.004; 06.02.08.001--
Blood disorder01.05.01.004--Not Available
Vulvovaginal mycotic infection21.14.02.004; 11.03.05.004--Not Available
Bone marrow failure01.03.03.005--
Candida infection11.03.03.021--
The 2th Page    First    Pre   2    Total 2 Pages